T. Rowe Price Investment Management, Inc. Biolife Solutions Inc Transaction History
T. Rowe Price Investment Management, Inc.
- $151 Billion
- Q1 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Biolife Solutions Inc stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 1,348,008 shares of BLFS stock, worth $29 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,348,008Holding current value
$29 Million% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding BLFS
# of Institutions
202Shares Held
48.8MCall Options Held
2.5KPut Options Held
182K-
Casdin Capital, LLC New York, NY8.71MShares$187 Million23.27% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$118 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA3.55MShares$76.3 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$60.3 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY1.53MShares$33 Million0.21% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $918M
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...